849
Views
35
CrossRef citations to date
0
Altmetric
Research Article

2,3,7,8-Tetrachlorodibenzo-p-dioxin Alters the Differentiation of Alloreactive CD8+ T Cells Toward a Regulatory T Cell Phenotype by a Mechanism that is Dependent on Aryl Hydrocarbon Receptor in CD4+ T Cells

, &
Pages 81-91 | Received 18 Sep 2007, Accepted 25 Oct 2007, Published online: 09 Oct 2008

REFERENCES

  • Bienvenu B., Martin B., Auffray C., Cordier C., Becourt C., Lucas B. Peripheral CD8+CSD25+ T-lymphocytes from MHC Class II-deficient mice exhibit regulatory activity. J. Immunol. 2005; 175: 246–253
  • Bisikirska B., Colgan J., Luban J., Bluestone J. A., Herold K. C. TCR stimulation with modified anti-CD3 mAb expands CD8+ T-cell population and induces CD8+CD25+ Tregs. J. Clin. Invest. 2005; 115: 2904–2913
  • Bluestone J. A., Abbas A. K. Natural versus adaptive regulatory T-cells. Nat. Rev. Immunol. 2003; 3: 253–257
  • Chen Z. M., O'Shaughnessy M. J., Gramaglia I., Panoskaltsis-Mortari A., Murphy W. J., Narula S., Roncarolo M. G., Blazar B. R. IL-10 and TGF-β induce alloreactive CD4+CD25− T-cells to acquire regulatory cell function. Blood 2003; 101: 5076–5083
  • Ciolino H. P., Daschner P. J., Yeh G. C. Dietary flavonols quercetin and kaempferol are ligands of the aryl hydrocarbon receptor that affect CYP1A1 transcription differentially. Biochem. J. 1999; 340: 715–722
  • Cortesini R., LeMaoult J., Ciubotariu R., Cortesini N. S. CD8+CD28− T-suppressor cells and the induction of antigen-specific, antigen-presenting cell-mediated suppression of TH reactivity. Immunol. Rev. 2001; 182: 201–206
  • Cosmi L., Liotta F., Lazzeri E., Francalanci M., Angeli R., Mazzinghi B., Santarlasci V., Manetti R., Vanini V., Romagnani P., Maggi E., Romagnani S., Annunziato F. Human CD8+CD25+ thymocytes share phenotypic and functional features with CD4+CD25+ regulatory thymocytes. Blood 2003; 102: 4107–4114
  • Denison M. S., Nagy S. R. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Ann. Rev. Pharmacol. Toxicol. 2003; 43: 309–334
  • Ema M., Ohe N., Suzuki M., Mimura J., Sogawa K., Ikawa S., Fujii-Kuriyama Y. Dioxin binding activities of polymorphic forms of mouse and human aryl hydrocarbon receptors. J. Biol. Chem. 1994; 269: 27337–27343
  • Endharti A. T., Rifa I. M., Shi Z., Fukuoka Y., Nakahara Y., Kawamoto Y., Takeda K., Isobe K., Suzuki H. Cutting edge: CD8+CD122+ regulatory T-cells produce IL-10 to suppress IFN-γ production and proliferation of CD8+ T-cells. J. Immunol. 2005; 175: 7093–7097
  • Filaci G., Fravega M., Negrini S., Procopio F., Fenoglio D., Rizzi M., Brenci S., Contini P., Olive D., Ghio M., Setti M., Accolla R. S., Puppo F., Indiveri F. Non-antigen specific CD8+ T-suppressor lymphocytes originate from CD8+CD28− T-cells and inhibit both T-cell proliferation and CTL function. Hum. Immunol. 2004; 65: 142–156
  • Funatake C. J., Dearstyne E. A., Steppan L. B., Shepherd D. M., Spanjaard E. S., Marshak-Rothstein A., Kerkvliet N. I. Early consequences of 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure on the activation and survival of antigen-specific T-cells. Toxicol. Sci. 2004; 82: 129–142
  • Funatake C. J., Marshall N. B., Steppan L. B., Mourich D. V., Kerkvliet N. I. Cutting edge: Activation of the aryl hydrocarbon receptor by 2,3,7,8-tetrachlorodibenzo-p-dioxin generates a population of CD4+CD25+ cells with characteristics of regulatory T-cells. J. Immunol. 2005; 175: 4184–4188
  • Giblin P. A., Hwang S. T., Katsumoto T. R., Rosen S. D. Ligation of L-selectin on T-lymphocytes activates β 1 integrins and promotes adhesion to fibronectin. J. Immunol. 1997; 159: 3498–3507
  • Gu Y.-Z., Hogenesch J. B., Bradfield C. A. The PAS Superfamily: Sensors of environmental and developmental signals. Ann. Rev. Pharmacol. Toxicol. 2000; 40: 519–561
  • Gudmundsdottir H., Wells A. D., Turka L. A. Dynamics and requirements of T-cell clonal expansion in vivo at the single-cell level: Effector function is linked to proliferative capacity. J. Immunol. 1999; 162: 5212–5223
  • Herold K. C., Hagopian W., Auger J. A., Poumian-Ruiz E., Taylor L., Donaldson D., Gitelman S. E., Harlan D. M., Xu D., Zivin R. A., Bluestone J. A. Anti-CD3 monoclonal antibody in new-onset Type 1 diabetes mellitus. New Engl. J. Med. 2002; 346: 1692–1698
  • Horwitz D. A., Zheng S. G., Gray J. D. The role of the combination of IL-2 and TGF-β or IL-10 in the generation and function of CD4+CD25+ and CD8+ regulatory T-cell subsets. J. Leukocyte Biol. 2003; 74: 471–478
  • Hu D., Ikizawa K., Lu L., Sanchirico M. E., Shinohara M. L., Cantor H. Analysis of regulatory CD8 T-cells in Qa-1-deficient mice. Nat. Immunol. 2004; 5: 516–523
  • Jeon M. S., Esser C. The murine IL-2 promoter contains distal regulatory elements responsive to the Ah receptor, a member of the evolutionarily conserved bHLH-PAS transcription factor family. J. Immunol. 2000; 165: 6975–6983
  • Jiang H., Kashleva H., Xu L. X., Forman J., Flaherty L., Pernis B., Braunstein N. S., Chess L. T-Cell vaccination induces T-cell receptor Vbeta-specific Qa-1-restricted regulatory CD8(+) T-cells. Proc. Natl. Acad. Sci. USA 1998; 95: 4533–4537
  • Jonuleit H., Schmitt E., Kakirman H., Stassen M., Knop J., Enk A. H. Infectious tolerance: Human CD25+ regulatory T-cells convey suppressor activity to conventional CD4+ T-helper cells. J. Exp. Med. 2002; 196: 255–260
  • Kerkvliet N. I. Recent advances in understanding the mechanisms of TCDD immunotoxicity. Int. Immunopharmacol. 2002; 2: 277–291
  • Kerkvliet N. I., Shepherd D. M., Baecher-Steppan L. T-Lymphocytes are direct, aryl hydrocarbon receptor (AhR)-dependent targets of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): AhR expression in both CD4+ and CD8+ T-cells is necessary for full suppression of a cytotoxic T-lymphocyte response by TCDD. Toxicol. Appl. Pharmacol. 2002; 185: 146–152
  • Kruisbeek A. M., Shevach E. M., Thornton A. M. Proliferative assays for T-cell function. Current Protocols in Immunology, J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, W. Strober. John Wiley & Sons, Inc., New York 2004; 13.12.11–13.12.20
  • Lai Z. W., Hundeiker C., Gleichmann E., Esser C. Cytokine gene expression during ontogeny in murine thymus on activation of the aryl hydrocarbon receptor by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Mol. Pharmacol. 1997; 52: 30–37
  • Lawrence B. P., Kerkvliet N. I. Immune modulation by TCDD and related polyhalogenated aromatic hydrocarbons. Immunotoxicology and Immunopharmacology, R. Luebke, R. House, I. Kimber. Taylor & Francis, Boca Raton, FL 2007; 239–258
  • Maile R., Pop S. M., Tisch R., Collins E. J., Cairns B. A., Frelinger J. A. Low-avidity CD8lo T-cells induced by incomplete antigen stimulation in vivo regulate naive higher avidity CD8hi T-cell responses to the same antigen. Eur. J. Immunol. 2006; 36: 397–410
  • Mimura J., Fujii-Kuriyama Y. Functional role of AhR in the expression of toxic effects by TCDD. Biochim. Biophys. Acta 2003; 1619: 263–268
  • Noble A., Giorgini A., Leggat J. A. Cytokine-induced IL-10-secreting CD8 T-cells represent a phenotypically distinct suppressor T-cell lineage. Blood 2006; 107: 4475–4483
  • Oehen S., Brduscha-Riem K. Differentiation of naive CTL to effector and memory CTL: Correlation of effector function with phenotype and cell division. J. Immunol. 1998; 161: 5338–5346
  • Qin S., Cobbold S. P., Pope H., Elliott J., Kioussis D., Davies J., Waldmann H. “Infectious” transplantation tolerance. Science 1993; 259: 974–977
  • Rifa'i M., Kawamoto Y., Nakashima I., Suzuki H. Essential roles of CD8+CD122+ regulatory T-cells in the maintenance of T-cell homeostasis. J Exp Med 2004; 200: 1123–1134
  • Schmidt J. V., Bradfield C. A. Ah receptor signaling pathways. Annu. Rev. Cell Dev. Biol. 1996; 12: 55–89
  • Sharma S., Dominguez A. L., Lustgarten J. High accumulation of T-regulatory cells prevents the activation of immune responses in aged animals. J. Immunol. 2006; 177: 8348–8355
  • Shepherd D. M., Dearstyne E. A., Kerkvliet N. I. The effects of TCDD on the activation of ovalbumin (OVA)-specific DO11.10 transgenic CD4(+) T-cells in adoptively transferred mice. Toxicol. Sci. 2000; 56: 340–350
  • Shevach E. M. From vanilla to 28 flavors: Multiple varieties of T-regulatory cells. Immunity 2006; 25: 195–201
  • Stassen M., Schmitt E., Jonuleit H. Human CD(4+)CD(25+) regulatory T-cells and infectious tolerance. Transplantation 2004; 77: S23–S25
  • Sun Y. V., Boverhof D. R., Burgoon L. D., Fielden M. R., Zacharewski T. R. Comparative analysis of dioxin response elements in human, mouse and rat genomic sequences. Nucl. Acids Res. 2004; 32: 4512–4523
  • Takahashi T., Tagami T., Yamazaki S., Uede T., Shimizu J., Sakaguchi N., Mak T. W., Sakaguchi S. Immunologic self-tolerance maintained by CD25+CD4+ regulatory T-cells constitutively expressing cytotoxic T-lymphocyte-associated antigen-4. J. Exp. Med. 2000; 192: 303–310
  • Tang Q., Boden E. K., Henriksen K. J., Bour-Jordan H., Bi M., Bluestone J. A. Distinct roles of CTLA-4 and TGF-β in CD4+CD25+ regulatory T-cell function. Eur. J. Immunol. 2004; 34: 2996–3005
  • Tang X. L., Smith T. R., Kumar V. Specific control of immunity by regulatory CD8 T-cells. Cell. Mol. Immunol. 2005; 2: 11–19
  • Vieira P. L., Christensen J. R., Minaee S., O'Neill E. J., Barrat F. J., Boonstra A., Barthlott T., Stockinger B., Wraith D. C., O'Garra A. IL-10-secreting regulatory T-cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T-cells. J. Immunol. 2004; 172: 5986–5993
  • Vorderstrasse B. A., Steppan L. B., Silverstone A. E., Kerkvliet N. I. Aryl hydrocarbon receptor-deficient mice generate normal immune responses to model antigens and are resistant to TCDD-induced immune suppression. Toxicol. Appl. Pharmacol. 2001; 171: 157–164
  • Waldmann H., Adams E., Fairchild P., Cobbold S. Infectious tolerance and the long-term acceptance of transplanted tissue. Immunol. Rev. 2006; 212: 301–313
  • Walsh P. T., Taylor D. K., Turka L. A. Tregs and transplantation tolerance. J. Clin. Invest. 2004; 114: 1398–1403
  • Wei S., Kryczek I., Zou L., Daniel B., Cheng P., Mottram P., Curiel T., Lange A., Zou W. Plasmacytoid dendritic cells induce CD8+ regulatory T-cells in human ovarian carcinoma. Cancer Res. 2005; 65: 5020–5026
  • Woodle E. S., Xu D., Zivin R. A., Auger J., Charette J., O'Laughlin R., Peace D., Jollife L. K., Haverty T., Bluestone J. A., Thistlethwaite J. R., Jr. Phase I trial of a humanized, Fc receptor nonbinding OKT3 antibody, huOKT3gamma1(Ala-Ala) in the treatment of acute renal allograft rejection. Transplantation 1999; 68: 608–616
  • Zheng S. G., Wang J. H., Gray J. D., Soucier H., Horwitz D. A. Natural and induced CD4+CD25+ cells educate CD4+CD25− cells to develop suppressive activity: The role of IL-2, TGF-β, and IL-10. J, Immunol 2004a; 172: 5213–5221
  • Zheng S. G., Wang J. H., Koss M. N., Quismorio F., Jr., Gray J. D., Horwitz D. A. CD4+ and CD8+ regulatory T-cells generated ex vivo with IL-2 and TGF-β suppress a stimulatory graft-versus-host disease with a lupus-like syndrome. J. Immunol. 2004b; 172: 1531–1539

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.